This article is based on a consensus conference, promoted and supported by the
International Federation of Clinical Neurophysiology (IFCN), which took place in Siena (Italy) …

Rigorous evidence identification is essential for systematic reviews and meta‐analyses
(evidence syntheses) because the sample selection of relevant studies determines a …

Repetitive transcranial magnetic stimulation (rTMS) is emerging as a non-invasive
therapeutic strategy in the battle against Alzheimer's disease. Alzheimer's disease patients …

Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Abstract Treatment-resistant depression (TRD) is a subset of Major Depressive Disorder
which does not respond to traditional and first-line therapeutic options. There are several …

Background Treatment-resistant major depressive disorder is common; repetitive
transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side …

Abstract Treatment outcomes for major depressive disorder (MDD) need to be improved.
Presently, no clinically relevant tools have been established for stratifying subgroups or …

Importance Treatment-resistant depression (TRD) is common in older adults. Bilateral
repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex for 48 …

Background The degree of efficacy, safety, quality, and certainty of meta-analytic evidence of
biological non-pharmacological treatments in mental disorders is unclear. Methods We …

Background The left dorsolateral prefrontal cortex is a prime target for repetitive transcranial
magnetic stimulation (TMS) to treat neuropsychiatric disorders; thus, abundant efficacy data …